Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Renal Drugs Market Growth (Status and Outlook) 2022-2028

  • LP 4822942
  • 88 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Renal Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Renal Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Renal Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Renal Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Renal Drugs market, reaching US$ million by the year 2028. As for the Europe Renal Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Renal Drugs players cover Mylan, Roche Holding, Endo International, and Bausch Health Companies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Drugs market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Oral

Injections

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital Pharmacy

Retail Pharmacies

Drug Stores

Online Pharmacy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Mylan

Roche Holding

Endo International

Bausch Health Companies

Apotex

Cardinal Health

Fresenius

Dava Pharmaceuticals

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Renal Drugs Market Size 2017-2028

2.1.2 Renal Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Renal Drugs Segment by Type

2.2.1 Oral

2.2.2 Injections

2.3 Renal Drugs Market Size by Type

2.3.1 Renal Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Renal Drugs Market Size Market Share by Type (2017-2022)

2.4 Renal Drugs Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacies

2.4.3 Drug Stores

2.4.4 Online Pharmacy

2.4.5 Others

2.5 Renal Drugs Market Size by Application

2.5.1 Renal Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Renal Drugs Market Size Market Share by Application (2017-2022)

3 Renal Drugs Market Size by Player

3.1 Renal Drugs Market Size Market Share by Players

3.1.1 Global Renal Drugs Revenue by Players (2020-2022)

3.1.2 Global Renal Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Renal Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Renal Drugs by Regions

4.1 Renal Drugs Market Size by Regions (2017-2022)

4.2 Americas Renal Drugs Market Size Growth (2017-2022)

4.3 APAC Renal Drugs Market Size Growth (2017-2022)

4.4 Europe Renal Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Renal Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Renal Drugs Market Size by Country (2017-2022)

5.2 Americas Renal Drugs Market Size by Type (2017-2022)

5.3 Americas Renal Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Renal Drugs Market Size by Region (2017-2022)

6.2 APAC Renal Drugs Market Size by Type (2017-2022)

6.3 APAC Renal Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Renal Drugs by Country (2017-2022)

7.2 Europe Renal Drugs Market Size by Type (2017-2022)

7.3 Europe Renal Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Renal Drugs by Region (2017-2022)

8.2 Middle East & Africa Renal Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Renal Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Renal Drugs Market Forecast

10.1 Global Renal Drugs Forecast by Regions (2023-2028)

10.1.1 Global Renal Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Renal Drugs Forecast

10.1.3 APAC Renal Drugs Forecast

10.1.4 Europe Renal Drugs Forecast

10.1.5 Middle East & Africa Renal Drugs Forecast

10.2 Americas Renal Drugs Forecast by Country (2023-2028)

10.2.1 United States Renal Drugs Market Forecast

10.2.2 Canada Renal Drugs Market Forecast

10.2.3 Mexico Renal Drugs Market Forecast

10.2.4 Brazil Renal Drugs Market Forecast

10.3 APAC Renal Drugs Forecast by Region (2023-2028)

10.3.1 China Renal Drugs Market Forecast

10.3.2 Japan Renal Drugs Market Forecast

10.3.3 Korea Renal Drugs Market Forecast

10.3.4 Southeast Asia Renal Drugs Market Forecast

10.3.5 India Renal Drugs Market Forecast

10.3.6 Australia Renal Drugs Market Forecast

10.4 Europe Renal Drugs Forecast by Country (2023-2028)

10.4.1 Germany Renal Drugs Market Forecast

10.4.2 France Renal Drugs Market Forecast

10.4.3 UK Renal Drugs Market Forecast

10.4.4 Italy Renal Drugs Market Forecast

10.4.5 Russia Renal Drugs Market Forecast

10.5 Middle East & Africa Renal Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Renal Drugs Market Forecast

10.5.2 South Africa Renal Drugs Market Forecast

10.5.3 Israel Renal Drugs Market Forecast

10.5.4 Turkey Renal Drugs Market Forecast

10.5.5 GCC Countries Renal Drugs Market Forecast

10.6 Global Renal Drugs Forecast by Type (2023-2028)

10.7 Global Renal Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Mylan

11.1.1 Mylan Company Information

11.1.2 Mylan Renal Drugs Product Offered

11.1.3 Mylan Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Mylan Main Business Overview

11.1.5 Mylan Latest Developments

11.2 Roche Holding

11.2.1 Roche Holding Company Information

11.2.2 Roche Holding Renal Drugs Product Offered

11.2.3 Roche Holding Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Roche Holding Main Business Overview

11.2.5 Roche Holding Latest Developments

11.3 Endo International

11.3.1 Endo International Company Information

11.3.2 Endo International Renal Drugs Product Offered

11.3.3 Endo International Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Endo International Main Business Overview

11.3.5 Endo International Latest Developments

11.4 Bausch Health Companies

11.4.1 Bausch Health Companies Company Information

11.4.2 Bausch Health Companies Renal Drugs Product Offered

11.4.3 Bausch Health Companies Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bausch Health Companies Main Business Overview

11.4.5 Bausch Health Companies Latest Developments

11.5 Apotex

11.5.1 Apotex Company Information

11.5.2 Apotex Renal Drugs Product Offered

11.5.3 Apotex Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Apotex Main Business Overview

11.5.5 Apotex Latest Developments

11.6 Cardinal Health

11.6.1 Cardinal Health Company Information

11.6.2 Cardinal Health Renal Drugs Product Offered

11.6.3 Cardinal Health Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Cardinal Health Main Business Overview

11.6.5 Cardinal Health Latest Developments

11.7 Fresenius

11.7.1 Fresenius Company Information

11.7.2 Fresenius Renal Drugs Product Offered

11.7.3 Fresenius Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Fresenius Main Business Overview

11.7.5 Fresenius Latest Developments

11.8 Dava Pharmaceuticals

11.8.1 Dava Pharmaceuticals Company Information

11.8.2 Dava Pharmaceuticals Renal Drugs Product Offered

11.8.3 Dava Pharmaceuticals Renal Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Dava Pharmaceuticals Main Business Overview

11.8.5 Dava Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Renal Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Oral

Table 3. Major Players of Injections

Table 4. Renal Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Renal Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Renal Drugs Market Size Market Share by Type (2017-2022)

Table 7. Renal Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Renal Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Renal Drugs Market Size Market Share by Application (2017-2022)

Table 10. Global Renal Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Renal Drugs Revenue Market Share by Player (2020-2022)

Table 12. Renal Drugs Key Players Head office and Products Offered

Table 13. Renal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Renal Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Renal Drugs Market Size Market Share by Regions (2017-2022)

Table 18. Americas Renal Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Renal Drugs Market Size Market Share by Country (2017-2022)

Table 20. Americas Renal Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Renal Drugs Market Size Market Share by Type (2017-2022)

Table 22. Americas Renal Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Renal Drugs Market Size Market Share by Application (2017-2022)

Table 24. APAC Renal Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Renal Drugs Market Size Market Share by Region (2017-2022)

Table 26. APAC Renal Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Renal Drugs Market Size Market Share by Type (2017-2022)

Table 28. APAC Renal Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Renal Drugs Market Size Market Share by Application (2017-2022)

Table 30. Europe Renal Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Renal Drugs Market Size Market Share by Country (2017-2022)

Table 32. Europe Renal Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Renal Drugs Market Size Market Share by Type (2017-2022)

Table 34. Europe Renal Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Renal Drugs Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Renal Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Renal Drugs Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Renal Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Renal Drugs Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Renal Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Renal Drugs Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Renal Drugs

Table 43. Key Market Challenges & Risks of Renal Drugs

Table 44. Key Industry Trends of Renal Drugs

Table 45. Global Renal Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Renal Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Renal Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Renal Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Renal Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Renal Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 51. Mylan Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 52. Mylan Renal Drugs Product Offered

Table 53. Mylan Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Mylan Main Business

Table 55. Mylan Latest Developments

Table 56. Roche Holding Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 57. Roche Holding Renal Drugs Product Offered

Table 58. Roche Holding Main Business

Table 59. Roche Holding Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Roche Holding Latest Developments

Table 61. Endo International Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 62. Endo International Renal Drugs Product Offered

Table 63. Endo International Main Business

Table 64. Endo International Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Endo International Latest Developments

Table 66. Bausch Health Companies Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 67. Bausch Health Companies Renal Drugs Product Offered

Table 68. Bausch Health Companies Main Business

Table 69. Bausch Health Companies Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Bausch Health Companies Latest Developments

Table 71. Apotex Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 72. Apotex Renal Drugs Product Offered

Table 73. Apotex Main Business

Table 74. Apotex Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Apotex Latest Developments

Table 76. Cardinal Health Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 77. Cardinal Health Renal Drugs Product Offered

Table 78. Cardinal Health Main Business

Table 79. Cardinal Health Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Cardinal Health Latest Developments

Table 81. Fresenius Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 82. Fresenius Renal Drugs Product Offered

Table 83. Fresenius Main Business

Table 84. Fresenius Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Fresenius Latest Developments

Table 86. Dava Pharmaceuticals Details, Company Type, Renal Drugs Area Served and Its Competitors

Table 87. Dava Pharmaceuticals Renal Drugs Product Offered

Table 88. Dava Pharmaceuticals Main Business

Table 89. Dava Pharmaceuticals Renal Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Dava Pharmaceuticals Latest Developments

List of Figures

Figure 1. Renal Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Renal Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Renal Drugs Market Size Market Share by Type in 2021

Figure 7. Renal Drugs in Hospital Pharmacy

Figure 8. Global Renal Drugs Market: Hospital Pharmacy (2017-2022) & ($ Millions)

Figure 9. Renal Drugs in Retail Pharmacies

Figure 10. Global Renal Drugs Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Renal Drugs in Drug Stores

Figure 12. Global Renal Drugs Market: Drug Stores (2017-2022) & ($ Millions)

Figure 13. Renal Drugs in Online Pharmacy

Figure 14. Global Renal Drugs Market: Online Pharmacy (2017-2022) & ($ Millions)

Figure 15. Renal Drugs in Others

Figure 16. Global Renal Drugs Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Renal Drugs Market Size Market Share by Application in 2021

Figure 18. Global Renal Drugs Revenue Market Share by Player in 2021

Figure 19. Global Renal Drugs Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Renal Drugs Market Size 2017-2022 ($ Millions)

Figure 21. APAC Renal Drugs Market Size 2017-2022 ($ Millions)

Figure 22. Europe Renal Drugs Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Renal Drugs Market Size 2017-2022 ($ Millions)

Figure 24. Americas Renal Drugs Value Market Share by Country in 2021

Figure 25. Americas Renal Drugs Consumption Market Share by Type in 2021

Figure 26. Americas Renal Drugs Market Size Market Share by Application in 2021

Figure 27. United States Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Renal Drugs Market Size Market Share by Region in 2021

Figure 32. APAC Renal Drugs Market Size Market Share by Application in 2021

Figure 33. China Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Renal Drugs Market Size Market Share by Country in 2021

Figure 40. Europe Renal Drugs Market Size Market Share by Type in 2021

Figure 41. Europe Renal Drugs Market Size Market Share by Application in 2021

Figure 42. Germany Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Renal Drugs Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Renal Drugs Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Renal Drugs Market Size Market Share by Application in 2021

Figure 50. Egypt Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Renal Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 56. APAC Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 57. Europe Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 59. United States Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 60. Canada Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 63. China Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Japan Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 65. Korea Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 67. India Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Australia Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Germany Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 70. France Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 71. UK Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 72. Italy Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Russia Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 74. Spain Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 77. Israel Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Renal Drugs Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Renal Drugs Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390